Effect of a new antispasticity drug on neurogenic bladder function: preliminary report.
D000328:Adult; D000613:Aminobutyrates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology; D009119:Muscle Contraction / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D013119:Spinal Cord Injuries / Q000503:physiopathology; D014527:Uric Acid / Q000097:blood; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000503:physiopathology
D000613:Aminobutyrates; D001555:Benzene Derivatives; D014527:Uric Acid